Vivet Announces Multiple Projects Update, Including New VTX-803 Preclinical data To Be Presented At 2021 ASGCT Annual Meeting
Vivet Therapeutics Announces Multiple Projects Update, Including New VTX-803 Preclinical data To Be Presented At 2021 American Society Of Gene And Cell Therapy Annual Meeting
Mirum Pharmaceuticals and Vivet Therapeutics Enter into Exclusive Worldwide Option and License Agreement for Vivet’s PFIC Gene Therapy Programs
Mirum Pharmaceuticals and Vivet Therapeutics Enter into Exclusive Worldwide Option and License Agreement for Vivet’s Gene Therapy Programs Targeting Progressive Familial Intrahepatic Cholestasis
VIVET ATTENDING ARM 2021 CELL & GENE MEETING ON THE MED
Jean-Philippe Combal, Vivet CEO, will be attending a panel during the Cell & Gene Meeting on the Med – virtual, organized by the ARM on April 6-9, 2021. The panel, “TRENDS AND CHALLENGES IN GENE THERAPY IN EUROPE”, will be held on April 7, 3-4pm CET.
Vivet and Pfizer Inc. Announce FDA Authorization to Proceed with GATEWAY, the Phase 1/2 Study for VTX-801, Vivet’s Investigational Gene Therapy for WD
Vivet Therapeutics and Pfizer Inc. Announce FDA Authorization to Proceed with GATEWAY, the Phase 1/2 Study for VTX-801, Vivet’s Investigational Gene Therapy for Wilson Disease
VIVET ATTENDING JEFFERIES 2020 VIRTUAL LONDON HEALTHCARE CONFERENCE
Jean-Philippe Combal, Vivet Therapeutics’ CEO, and Thomas Daniel, BD Director, will be hosting 1×1 meetings during Jefferies 2020 London Healthcare Conference on November 17-19.
VIVET PRESENTING DURING 2020 4th ANNUAL GENE THERAPY FOR RARE DISORDERS EUROPE CONFERENCE
Anne Douar, Chief Development Officer of Vivet Therapeutics, will give a presentation
VIVET ATTENDING CHARDAN’S 4th ANNUAL GENETIC MEDICINES CONFERENCE
VIVET ATTENDING CHARDAN’S 4th ANNUAL GENETIC MEDICINES CONFERENCE
VIVET IS PARTICIPATING TO THE HEALTHTECH INNOVATION DAYS 2020 (HTID) IN PARIS
VIVET ATTENDING THE HEALTHTECH INNOVATION DAYS (HTID) IN PARIS
VIVET IS PARTICIPATING TO THE PAEDIATRIC CHOLESTASIS WORKSHOP – PART ONE 2020
Bernard Benichou Vivet Therapeutics’ CMO will be participating to a panel and Jean-Philippe Combal, CEO and Sonia Valero, Head of Clinical Operations…
Vivet Therapeutics and Pfizer Inc. Enter into Manufacturing Agreement for Vivet’s Investigational Gene Therapy for Wilson Disease
Vivet Therapeutics and Pfizer Inc. Enter into Manufacturing Agreement for Vivet’s Investigational Gene Therapy for Wilson Disease
